(Q45108167)

9 December 2017

title

Suppression of luteal phase, but not midcycle, prolactin levels by chronic follicular phase opiate antagonism (English)

1 reference

9 December 2017

Brzyski RG

1

1 reference

9 December 2017

Viniegra A

series ordinal

2

1 reference

9 December 2017

Archer DF

series ordinal

3

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

9 December 2017

published in

Fertility and Sterility

1 reference

9 December 2017

volume

68

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

855-859

1 reference

Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Hormonal and metabolic responses to an enkephalin analogue in normal man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

beta-Endorphin and naloxone in psychiatric patients: clinical and biological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Intravenous infusion of beta-endorphin increases serum prolactin, but not growth hormone or cortisol, in depressed subjects and withdrawing methadone addicts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Effects of Exogenous βh-Endorphin on Pituitary Hormone Secretionand Its Disappearance Rate in Normal Human Subjects*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Failure of naloxone to influence physiological growth hormone and prolactin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Failure of naloxone to alter exercise-induced growth hormone and prolactin release in normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Naloxone-induced prolactin secretion in women: evidence against a direct prolactin stimulatory effect of endogenous opioids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Sustained effects of opioid antagonism during the normal human luteal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

β-Endorphin in Hypophyseal Portal Blood: Variations throughout the Menstrual Cycle*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

The role of endogenous opiates in LH secretion during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Effect of sex steroids on beta-endorphin in hypophyseal portal blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Prolactin levels during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Serum Prolactin Levels During the Menstrual Cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Periovulatory enhancement of spontaneous prolactin secretion in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Changes in plasma levels of prolactin, in relation to those of FSH, oestradiol, androstenedione and progesterone around the preovulatory surge of LH in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Physiologic and pathologic profiles of circulating human prolactin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Circulating levels of prolactin during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Effects of Estrogen on Primary Ovine Pituitary Cell Cultures: Stimulation of Prolactin Secretion, Synthesis, and Preprolactin Messenger Ribonucleic Acid Activity*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

A possible role for prolactin in control of steroid secretion by the human Graafian follicle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Nontolerance to the opioid antagonism of naltrexone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Effect of opioid receptor antagonism on proopiomelanocortin peptide levels and gene expression in the hypothalamus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Pre- and posttranslational regulation of beta-endorphin biosynthesis in the CNS: effects of chronic naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Naloxone and naltrexone. Application in COPD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

Physiological profiles of episodic progesterone release during the midluteal phase of the human menstrual cycle: analysis of circadian and ultradian rhythms, discrete pulse properties, and correlations with simultaneous luteinizing hormone release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900357-9

10.1016/S0015-0282(97)00357-9

7 January 2021

Identifiers

DOI

1 reference

9 December 2017

1 reference